Medicine and Dentistry
Association
100%
Serum
100%
Evaluation Study
100%
Brain Derived Neurotrophic Factor
100%
Hyperbilirubinemia
100%
Bilirubin
22%
Gestational Age
16%
Hospital
11%
Prematurity
11%
Risk Assessment
11%
Neonatal Hyperbilirubinemia
11%
Life
5%
Laboratory
5%
Cross Sectional Study
5%
Blood Sampling
5%
Cell Damage
5%
Brain
5%
Clinical Decision Making
5%
Neurotropic Agent
5%
INIS
levels
100%
brain
100%
evaluation
100%
neonates
100%
bilirubin
36%
hospitals
18%
biochemistry
9%
risks
9%
colleges
9%
control
9%
comparative evaluations
9%
blood
9%
damage
9%
tools
9%
laboratories
9%
correlations
9%
risk assessment
9%
decision making
9%
Nursing and Health Professions
Neonates
100%
Evaluation Study
100%
Hyperbilirubinemia
100%
Brain Derived Neurotrophic Factor
100%
Bilirubin
22%
Gestational Age
16%
Prematurity
11%
Neonatal Hyperbilirubinemia
11%
Hospital
5%
Control
5%
Cross-Sectional Study
5%
Device Material
5%
Sample
5%
Clinical Decision Making
5%
Laboratory
5%
Hospital Admission
5%
Blood Level
5%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Derived Neurotrophic Factor
100%
Hyperbilirubinemia
100%
Bilirubin
22%
Prematurity
11%
Neonatal Hyperbilirubinemia
11%
Cross-Sectional Study
5%
Neurotropic Agent
5%